APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vandetanib Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Vandetanib Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025171 pages

Choose your research edition.

Industry ResearchVandetanib Tablets Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Vandetanib Tablets Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Vandetanib Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vandetanib Tablets Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Vandetanib Tablets Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Vandetanib Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Vandetanib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vandetanib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vandetanib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Vandetanib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vandetanib Tablets include Lucius Pharma, AstraZeneca and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Vandetanib Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vandetanib Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vandetanib Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vandetanib Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Vandetanib Tablets Segment by Company

Lucius Pharma

AstraZeneca

Sanofi

Vandetanib Tablets Segment by Type

100mg per Tablet

300mg per Tablet

Vandetanib Tablets Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Vandetanib Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vandetanib Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vandetanib Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vandetanib Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vandetanib Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vandetanib Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Vandetanib Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Vandetanib Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Vandetanib Tablets Industry Trends Table 2. Vandetanib Tablets Industry Drivers Table 3. Vandetanib Tablets Industry Opportunities and Challenges Table 4. Vandetanib Tablets Industry Restraints Table 5. Global Vandetanib Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Vandetanib Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Vandetanib Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Vandetanib Tablets Sales Market Share by Manufacturers Table 9. Global Vandetanib Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Vandetanib Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Vandetanib Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Vandetanib Tablets Manufacturers, Product Type & Application Table 13. Global Vandetanib Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Vandetanib Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 100mg per Tablet Table 17. Major Manufacturers of 300mg per Tablet Table 18. Global Vandetanib Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Vandetanib Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Vandetanib Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Vandetanib Tablets Sales Market Share by Type (2021-2026) Table 22. Global Vandetanib Tablets Sales Market Share by Type (2027-2032) Table 23. Global Vandetanib Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Vandetanib Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Vandetanib Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Vandetanib Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Vandetanib Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital and Clinic Table 29. Major Manufacturers of Retail Pharmacies Table 30. Major Manufacturers of Other Table 31. Global Vandetanib Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Vandetanib Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Vandetanib Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Vandetanib Tablets Sales Market Share by Application (2021-2026) Table 35. Global Vandetanib Tablets Sales Market Share by Application (2027-2032) Table 36. Global Vandetanib Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Vandetanib Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Vandetanib Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Vandetanib Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Vandetanib Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Vandetanib Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Vandetanib Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Vandetanib Tablets Sales Market Share by Region (2021-2026) Table 44. Global Vandetanib Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Vandetanib Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Vandetanib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Vandetanib Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Vandetanib Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Vandetanib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Vandetanib Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Vandetanib Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Vandetanib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Vandetanib Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Vandetanib Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Vandetanib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Vandetanib Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Vandetanib Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Vandetanib Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Vandetanib Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Vandetanib Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Vandetanib Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Vandetanib Tablets Revenue Market Share by Region (2027-2032) Table 63. Lucius Pharma Company Information Table 64. Lucius Pharma Business Overview Table 65. Lucius Pharma Vandetanib Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Lucius Pharma Vandetanib Tablets Product Portfolio Table 67. Lucius Pharma Recent Development Table 68. AstraZeneca Company Information Table 69. AstraZeneca Business Overview Table 70. AstraZeneca Vandetanib Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. AstraZeneca Vandetanib Tablets Product Portfolio Table 72. AstraZeneca Recent Development Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Vandetanib Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sanofi Vandetanib Tablets Product Portfolio Table 77. Sanofi Recent Development Table 78. Key Raw Materials Table 79. Raw Materials Key Suppliers Table 80. Vandetanib Tablets Distributors List Table 81. Vandetanib Tablets Customers List Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Vandetanib Tablets Product Image Figure 2. Global Vandetanib Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vandetanib Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Vandetanib Tablets Sales (2021-2032) & (K Units) Figure 5. Global Vandetanib Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Vandetanib Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 100mg per Tablet Image Figure 9. 300mg per Tablet Image Figure 10. Global Vandetanib Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Vandetanib Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Vandetanib Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Vandetanib Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Vandetanib Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Vandetanib Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital and Clinic Image Figure 17. Retail Pharmacies Image Figure 18. Other Image Figure 19. Global Vandetanib Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Vandetanib Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Vandetanib Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Vandetanib Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Vandetanib Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Vandetanib Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Vandetanib Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Vandetanib Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Vandetanib Tablets Sales Market Share by Country (2021-2032) Figure 39. China Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Vandetanib Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Vandetanib Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Vandetanib Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Vandetanib Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Vandetanib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Vandetanib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Vandetanib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Vandetanib Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Vandetanib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Vandetanib Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Vandetanib Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg per Tablet
  • 300mg per Tablet
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Lucius Pharma
  • AstraZeneca
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Vandetanib Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Vandetanib Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Vandetanib Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Vandetanib Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Vandetanib Tablets Market Dynamics
  1. 2.1 Vandetanib Tablets Industry Trends
  2. 2.2 Vandetanib Tablets Industry Drivers
  3. 2.3 Vandetanib Tablets Industry Opportunities and Challenges
  4. 2.4 Vandetanib Tablets Industry Restraints
3 Vandetanib Tablets Market by Manufacturers
  1. 3.1 Global Vandetanib Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Vandetanib Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Vandetanib Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Vandetanib Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vandetanib Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Vandetanib Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Vandetanib Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vandetanib Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vandetanib Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vandetanib Tablets Tier 1, Tier 2, and Tier 3
4 Vandetanib Tablets Market by Type
  1. 4.1 Vandetanib Tablets Type Introduction
  2. 4.1.1 100mg per Tablet
  3. 4.1.2 300mg per Tablet
  4. 4.2 Global Vandetanib Tablets Sales by Type
  5. 4.2.1 Global Vandetanib Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Vandetanib Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Vandetanib Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Vandetanib Tablets Revenue by Type
  9. 4.3.1 Global Vandetanib Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Vandetanib Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Vandetanib Tablets Revenue Market Share by Type (2021-2032)
5 Vandetanib Tablets Market by Application
  1. 5.1 Vandetanib Tablets Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Vandetanib Tablets Sales by Application
  6. 5.2.1 Global Vandetanib Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vandetanib Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Vandetanib Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Vandetanib Tablets Revenue by Application
  10. 5.3.1 Global Vandetanib Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Vandetanib Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Vandetanib Tablets Revenue Market Share by Application (2021-2032)
6 Global Vandetanib Tablets Sales by Region
  1. 6.1 Global Vandetanib Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vandetanib Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Vandetanib Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Vandetanib Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Vandetanib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Vandetanib Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Vandetanib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Vandetanib Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Vandetanib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Vandetanib Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Vandetanib Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Vandetanib Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Vandetanib Tablets Revenue by Region
  1. 7.1 Global Vandetanib Tablets Revenue by Region
  2. 7.1.1 Global Vandetanib Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Vandetanib Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Vandetanib Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Vandetanib Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Vandetanib Tablets Revenue (2021-2032)
  8. 7.2.2 North America Vandetanib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Vandetanib Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Vandetanib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Vandetanib Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Vandetanib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Vandetanib Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Vandetanib Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Lucius Pharma
  2. 8.1.1 Lucius Pharma Company Information
  3. 8.1.2 Lucius Pharma Business Overview
  4. 8.1.3 Lucius Pharma Vandetanib Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lucius Pharma Vandetanib Tablets Product Portfolio
  6. 8.1.5 Lucius Pharma Recent Developments
  7. 8.2 AstraZeneca
  8. 8.2.1 AstraZeneca Company Information
  9. 8.2.2 AstraZeneca Business Overview
  10. 8.2.3 AstraZeneca Vandetanib Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AstraZeneca Vandetanib Tablets Product Portfolio
  12. 8.2.5 AstraZeneca Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Vandetanib Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Vandetanib Tablets Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vandetanib Tablets Value Chain Analysis
  2. 9.1.1 Vandetanib Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vandetanib Tablets Production Mode & Process
  6. 9.2 Vandetanib Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vandetanib Tablets Distributors
  9. 9.2.3 Vandetanib Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst